Citation: | LIANG Yiping, FU Wen, ZHANG Zhenhai, LYU Huixia. Pharmacodynamics study of Panax notoginseng saponins zein lipoprotein nanoparticles for cerebral ischemia reperfusion injury in rats[J]. Journal of China Pharmaceutical University, 2021, 52(3): 318-324. DOI: 10.11665/j.issn.1000-5048.20210308 |
[1] |
. Chin J Integr Med,2017,23(6):445-452.
|
[2] |
Yu YL,Sun GB,Luo Y,et al. Cardioprotective effects of notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic Reticulum stress- related signaling pathways[J]. Sci Rep,2016,6:21730.
|
[3] |
Yang X,Xiong X,Wang H,et al. Protective effects of Panax notoginseng saponins on cardiovascular diseases:a comprehensive overview of experimental studies[J]. Evid Based Complement Alternat Med,2014,2014:204840.
|
[4] |
Zhai YS,Du SY,Xu B,et al. O/W partition coefficient of PNS and absorption kinetics of it in rat intestine[J]. China J Chin Mater Med(中国中药杂志),2010,35(8):984-988.
|
[5] |
Lai L,Liu HG,Qin Y,et al. Effects of absorption enhancers on small intestinal absorption of Panax notoginseng saponins[J]. Chin J New Drugs(中国新药杂志),2011,20(10):909-913.
|
[6] |
Liao ZG,Han XZ,Li X,et al. Physicochemical property and protective effect on acute myocardial ischemia in rats of Panax notoginseng saponins-loaded complex nano vesicles[J]. Chin J New Drugs (中国新药杂志),2013,48(11):899-903.
|
[7] |
Hasegawa H,Sung JH,Matsumiya S,et al. Main ginseng saponin metabolites formed by intestinal bacteria[J]. Planta Med,1996,62(5):453-457.
|
[8] |
Liu HF,Yang JL,Du FF,et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats[J]. Drug Metab Dispos,2009,37(12):2290-2298.
|
[9] |
Guo YP,Shao L,Chen MY,et al. In vivo metabolic profiles of Panax notoginseng saponins mediated by gut microbiota in rats[J]. J Agric Food Chem,2020,68(25):6835-6844.
|
[10] |
Lai L,Liu HG,Lu SH,et al. Pharmacokinetics and correlation between in vivo absorption and in vitro release of Panax notoginseng saponins enteric microcapsule[J]. Chin J New Drugs(中国新药杂志),2012,21(6):693-696.
|
[11] |
Han M,Fu S,Fang XL. Screening of Panax notoginsenoside water in oil microemulsion formulations and their evaluation in vitro and in vivo[J]. Acta Pharm Sin(药学学报),2007,42(7):780-786.
|
[12] |
Liu Z,Zhang Q,Ding L,et al. Preparation procedure and pharmacokinetic study of water-in-oil nanoemulsion of Panax notoginseng saponins for improving the oral bioavailability[J]. Curr Drug Deliv,2016,13(4):600-610.
|
[13] |
Momany FA,Sessa DJ,Lawton JW,et al. Structural characterization of alpha-zein[J]. J Agric Food Chem,2006,54(2):543-547.
|
[14] |
Hong SS,Thapa RK,Kim JH,et al. Role of zein incorporation on hydrophobic drug-loading capacity and colloidal stability of phospholipid nanoparticles[J]. Colloids Surf B Biointerfaces,2018,171:514-521.
|
[15] |
Li M,Yu M. Development of a nanoparticle delivery system based on zein/polysaccharide complexes[J]. J Food Sci,2020,85(12):4108-4117.
|
[16] |
Xie ZH,Zhang ZH,Lv H. Rapamycin loaded TPGS-Lecithins-Zein nanoparticles based on core-shell structure for oral drug administration[J]. Int J Pharm,2019,568:118529.
|
[17] |
Cheng ZT,Yao K,Liu WW,et al. Preparation and characterization of composite delivery system of paclitaxel-loaded temperature sensitive liposome and siRNA-loaded gold nanostar[J]. J China Pharm Univ (中国药科大学学报),2017,48(4):445-452.
|
[18] |
Hao JM,Wang H,Li Q,et al. Preparation and in vitro studies of polysaccharide modified compound liposomes loaded with paclitaxe and doxorubicin[J]. J China Pharm Univ (中国药科大学学报),2017,48 (6) :680-686.
|
[19] |
Bin Sayeed MS,Karim SMR,Sharmin T,et al. Critical analysis on characterization,systemic effect,and therapeutic potential of beta-sitosterol:a plant-derived orphan phytosterol[J]. Medicines (Basel),2016,3 (4) :29.
|
[20] |
Huang LF,Chen CW,Zhang X,et al. Neuroprotective effect of curcumin against cerebral ischemia-reperfusion via mediating autophagy and inflammation[J]. J Mol Neurosci,2018,64(1):129-139.
|
[21] |
Zhang Y,Chen WA,Huang SS,et al. Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms[J]. Eur J Pharmacol,2016,771:145-151.
|
[22] |
Zou S,Zhang MX,Feng LM,et al. Protective effects of notoginsenoside R1 on cerebral ischemia-reperfusion injury in rats[J]. Exp Ther Med,2017,14(6):6012-6016.
|
[23] |
Jin Z,Guo P,Li X,et al. Neuroprotective effects of irisin against cerebral ischemia/ reperfusion injury via Notch signaling pathway[J]. Biomed Pharmacother,2019,120:109452.
|
[24] |
Lin J,Liang P,Huang Q,et al. Research progress of protective effect of Panax notoginseng saponins on cerebral ischemia injury[J]. World Latest Med Inf(世界最新医学信息文摘),2018,18(16):97-99.
|
[25] |
Bibi S,Kaur R,Henriksen-Lacey M,et al. Microscopy imaging of liposomes:from coverslips to environmental SEM[J]. Int J Pharm,2011,417(1/2):138-150.
|
[26] |
Majzoub RN,Ewert KK,Safinya CR. Cationic liposome—nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing[J]. Philos Trans A Math Phys Eng Sci,2016,374(2072):20150129.
|
[27] |
Almgren M ,Edwards K,Karlsson G. Cryo transmission electron microscopy of liposomes and related structures[J]. Colloids Surf A Physicochem Eng Asp,2000,174(1/2):3-21.
|
[28] |
Zhang CB,Shen MH,Teng FM,et al. Ultrasound-enhanced protective effect of tetramethylpyrazine via the ROS/HIF-1A signaling pathway in an in vitro cerebral ischemia/reperfusion injury model[J]. Ultrasound Med Biol,2018,44(8):1786-1798.
|
[29] |
He R,Jiang Y,Shi Y,et al. Curcumin-laden exosomes target ischemic brain tissue and alleviate cerebral ischemia-reperfusion injury by inhibiting ROS-mediated mitochondrial apoptosis[J]. Mater Sci Eng C Mater Biol Appl,2020,117:111314.
|
[30] |
Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury[J]. Free Radic Biol Med,1990,9(6):515-540.
|
[31] |
Kvansakul M,Hinds MG. Structural biology of the Bcl-2 family and its mimicry by viral proteins[J]. Cell Death Dis,2013,4:
|
[32] |
Li M,Yu M. Development of a nanoparticle delivery system based on zein/polysaccharide complexes[J]. J Food Sci,2020,85(12):4108-4117.
|
[33] |
Pascoli M,Lima DR,Fraceto LF. Zein nanoparticles and strategies to improve colloidal stability:a mini-review[J]. Front Chem,2018,6:6.
|
[1] | CAI Xu, WU Xiaoqian, HAN Lingfei, FENG Feng, QU Wei, LIU Wenyuan. Research progress on natural products regulating osteogenic differentiation[J]. Journal of China Pharmaceutical University, 2025, 56(1): 10-21. DOI: 10.11665/j.issn.1000-5048.2024101003 |
[2] | LU Ningshu, JI Tao, LU Yinglan, XU Xiyuan, GU Xiaochen, DING Yang. Drug delivery strategies and clinical research progress for encephalopathy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 577-589. DOI: 10.11665/j.issn.1000-5048.2024063001 |
[3] | YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205 |
[4] | WANG Chen, ZHANG Zhengping, LI Yinchun. Development strategy and clinical research progress of universal chimeric antigen receptor T-cell drugs[J]. Journal of China Pharmaceutical University, 2023, 54(2): 141-149. DOI: 10.11665/j.issn.1000-5048.20211125001 |
[5] | LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603 |
[6] | YANG Wanwan, YE Fangyu, WU Yujia, WANG Haochen, ZHAO Li. Research progress of PARP inhibitors in cancers and their drug resistance[J]. Journal of China Pharmaceutical University, 2022, 53(5): 525-534. DOI: 10.11665/j.issn.1000-5048.20220503 |
[7] | WANG Chen, XU Jun, LIU Yanhua, WANG Zengtao, HU Yue, TIAN Taiping, YI Mengjuan. Research progress on functionalized graphene oxide as drug carriers[J]. Journal of China Pharmaceutical University, 2017, 48(1): 117-124. DOI: 10.11665/j.issn.1000-5048.20170118 |
[8] | ZHANG Danfeng, JIAO Yu, LIU Yong, ZHANG Yanmin, ZHANG Zhimin, LU Tao. Progress of small molecule anti-tumor covalent drugs[J]. Journal of China Pharmaceutical University, 2017, 48(1): 1-7. DOI: 10.11665/j.issn.1000-5048.20170101 |
[9] | ZHANG Jinghui, WANG Yajing, HU Rong. Roles of Moesin in tumor progression[J]. Journal of China Pharmaceutical University, 2015, 46(3): 371-375. DOI: 10.11665/j.issn.1000-5048.20150319 |
[10] | Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80. |